Mortality and cancer incidence among patients treated with recombinant growth hormone during childhood in Israel-Reference-Cited by-同舟云学术

Mortality and cancer incidence among patients treated with recombinant growth hormone during childhood in Israel

Author:

Libruder Carmit¹,Blumenfeld Orit¹,Dichtiar Rita¹,Laron Zvi²,Zadik Zvi³,Shohat Tamy¹⁴,Afek Arnon⁵⁶

Affiliation:

1. Israel Center for Disease Control; Ministry of Health; Petah Tikva Israel

2. Endocrinology and diabetes Research Unit; Schneider Children's Medical Center; Petah Tikva Israel

3. Pediatric Endocrinology Unit; Kaplan Medical Center; Rehovot Israel

4. Department of Epidemiology and Preventive Medicine; School of Public Health; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

5. Israel Ministry of Health; Jerusalem Israel

6. Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference45 articles.

1. Long-term safety of recombinant human growth hormone in children;Bell;The Journal of Clinical Endocrinology and Metabolism,2010

5. Leukaemia in patients treated with growth hormone;The Lancet (London, England),1988

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献